Description:

ODM derived from http://clinicaltrials.gov/show/NCT00246974

Link:

http://clinicaltrials.gov/show/NCT00246974

Keywords:
Versions (1) ▾
  1. 12/11/13
Uploaded on:

December 11, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility DRKS00010322 NCT00246974 Bladder Cancer

Details

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age 18 Years and older
Histologically or cytologically-confirmed transitional cell carcinoma of the urothelium
Locally advanced or metastatic disease
At least one measurable lesion as defined by RECIST
Chemotherapy-naiv
Exclusion Criteria
Previous chemotherapy or other systemic antitumour therapy
Other co-existing malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma, cervical cancer in situ or locally limited prostate cancer
Back to the top of the page